Mri Interventions (MRIC) 1.0000 $MRIC
UC San Diego Health System Utilizes Platform Capabilities of MRI Interventions' ClearPoint System to Conduct Three Back-to-Back Procedures on a Single Patient
GlobeNewswire - Tue Aug 19, 7:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that neurosurgeons at UC San Diego Health System have utilized the ClearPoint system's platform capabilities to facilitate three same-setting MRI-guided neurosurgical procedures for a single patient. The team, led by Clark C. Chen, MD, PhD, vice-chairman of Academic Affairs for the Division of Neurosurgery at UC San Diego School of Medicine, biopsied a patient's brain tumor, aspirated a fluid-filled section of the tumor, and ablated the tumor, all under real-time MRI guidance enabled by the ClearPoint system in the hospital's diagnostic MRI suite.
MRI Interventions Announces Second Quarter 2014 Financial Results
GlobeNewswire - Thu Aug 07, 3:00PM CDT
-- Reports record total product revenues for the quarter
MRI Interventions to Report Second Quarter 2014 Financial Results
GlobeNewswire - Wed Jul 30, 7:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) announced today that it will release its second quarter 2014 financial results on Thursday, August 7, 2014, after the close of the U.S. financial markets. MRI Interventions will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the company's results.
Collaborations in Neurosurgery: MRI Interventions' ClearPoint System and Monteris Medical's NeuroBlate System Utilized Jointly to Enable Laser Ablation of Brain Tumor
GlobeNewswire - Mon Jun 23, 7:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) and Monteris Medical, Corp. jointly announced the utilization of their respective product platforms, the ClearPoint Neuro Intervention System and the NeuroBlate System, at UC San Diego Health System to enable minimally invasive (MR-guided) laser treatment in a patient afflicted with glioblastoma, a type of brain tumor. In a procedure led by Dr. Clark Chen, MD, PhD, Chief of Stereotactic and Radiosurgery and Vice-Chairman of Academic Affairs, MRI Interventions' ClearPoint System was used to establish the path to the tumor while Monteris' NeuroBlate System was used to ablate (heat) tumor cells. The entire procedure was performed within a diagnostic MRI suite at UC San Diego Health System.
MRI Interventions Reports 2013 Financial Results
GlobeNewswire - Thu Mar 20, 3:00PM CDT
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today its financial results for the fourth quarter and year ended December 31, 2013.
MRI Interventions Secures Commitments for $3,550,000 in Private Notes Offering
GlobeNewswire - Mon Mar 10, 7:10AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) announced today that it has entered into a purchase agreement with certain accredited investors for a private placement of securities. Upon a closing under the purchase agreement, which is subject to satisfaction of certain closing conditions, MRI Interventions will receive gross proceeds of $3,550,000, before offering-related expenses. The securities being sold by the company consist of 12% second-priority secured non-convertible promissory notes due 2019 and warrants to purchase 0.3 share of MRI Interventions' common stock for each dollar in principal amount of notes sold by the company, such warrants having an exercise price of $1.75 per share.
MRI Interventions Welcomes Medical Device Operational Specialist Timothy T. Richards to Board of Directors
GlobeNewswire - Mon Mar 10, 7:05AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that its Board of Directors has elected medical device executive Timothy T. Richards to the Board. Mr. Richards' diverse background in the medical technology industry includes over 25 years of international experience spanning the areas of operations, market and product development, and global commercial expansion.
MRI Interventions Announces Quarterly Product Revenues in Excess of $1 Million for the First Time for the Fourth Quarter of 2013
GlobeNewswire - Mon Mar 10, 7:00AM CDT
Full Year Product Revenues Exceed Guidance
MRI Interventions' ClearTrace System to be Featured in Presentation at the 2014 Western Atrial Fibrillation Symposium
GlobeNewswire - Thu Feb 27, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) announced today that its novel ClearTrace system for MRI-guided, catheter-based cardiac procedures will be featured in a presentation at the 7 Annual Western Atrial Fibrillation (AF) Symposium on Feb. 28-March 1 in Park City, Utah. The Western AF Symposium assembles a distinguished faculty of physicians and researchers from five continents to discuss the disorder, its relationship to heart failure, standards for patient care and technical advancements in the field.
MRI Interventions and Siemens Enter Into Agreement to Commercialize Next Generation Software Platform to Enable MRI-Guided, Catheter-Based Procedures
GlobeNewswire - Mon Feb 24, 7:08AM CST
MRI Interventions, Inc. (OTCQB:MRIC) and Siemens Healthcare announced today an agreement to co-develop and commercialize a next generation software platform that will enable minimally invasive catheter-based procedures to be performed under real-time magnetic resonance imaging (MRI) guidance. Today, virtually all catheter-based interventions are performed using fluoroscopy, an X-ray based imaging technique. The software platform, to be used in combination with companion MRI-guided catheters, will enable procedures to be performed under MRI guidance instead of fluoroscopic guidance. This shift to MRI-guided procedures is significant because MRI provides superior visualization of soft tissue, MRI provides continuous 3-D visualization, and MRI eliminates all radiation exposure for the patient and physician.
MRI Interventions to Present at Biotech Showcase 2014
GlobeNewswire - Thu Jan 09, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical technology company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today that Kimble Jenkins, MRI Interventions' Chief Executive Officer, will present at the 2014 Biotech Showcase in San Francisco, California on Wednesday, January 15, 2014. The presentation is scheduled to begin at 4:15 PM Pacific Time. A live webcast of the presentation will be available under the IR Calendar section of the MRI Interventions website. For those unable to listen to the live webcast, a replay will be available on MRI Interventions' website following the presentation.
MRI Interventions' ClearPoint System Utilized at Cincinnati Children's Hospital for Neurosurgical Shunt Placement
GlobeNewswire - Tue Jan 07, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced that the first real-time MRI-guided neurosurgical shunt placement using the company's ClearPoint(R) Neuro Intervention System has been performed at Cincinnati Children's Hospital, representing the latest application of the platform system and illustrating its utility in a wide range of neurosurgical procedures.
MRI Interventions Adds Industry Veteran Maria Sainz as New Board Member
GlobeNewswire - Mon Jan 06, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced that its Board of Directors has elected veteran medical device executive Maria Sainz as its newest director. Ms. Sainz's distinguished career in the medical device industry spans over 20 years, and includes 10 years as the top executive for both emerging businesses and large corporate divisions, strong commercial experience bringing therapies to market, significant international experience, and service on both public and private company boards.
OTC Daily Alert Stock Watch - MRI Interventions, Inc. (OTCQB:MRIC)
WorldStockWire - Wed Dec 18, 4:45AM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
MRI Interventions' ClearPoint Neuro Intervention System Recently Profiled by Boston's ABC-TV Affiliate
GlobeNewswire - Mon Dec 16, 7:00AM CST
The ClearPoint Neuro Intervention System developed by MRI Interventions, Inc. (OTCQB:MRIC) was featured December 10 in a television segment and article reported by the ABC-TV affiliate in Boston (WCVB-TV).
Brain Cancer Lesion Treated with Precisely-Aimed Laser Catheter using ClearPoint Neuro Intervention System in IMRIS iMRI
CNW Group - Tue Aug 20, 7:01AM CDT
Newest joint application of two enabling medical technologies exhibits benefits of intraoperative MRI for direct visualization when navigating to treat brain tumors and neurological disorders
MRI Interventions' ClearPoint System Enables Precise Delivery of Promising Investigational Gene Therapy in Parkinson's Disease Phase I Clinical Trial
Marketwire - Mon Aug 12, 9:07AM CDT
MRI Interventions, Inc. (OTCQB: MRIC) today announced treatment of the first patient in a Phase I clinical trial utilizing uniQure B.V.'s glial cell line-derived neurotrophic factor (GDNF) for treatment of Parkinson's disease. This gene therapy holds promise in the battle against the degenerative and debilitating disorder, which affects 1.5 million people in the United States. MRI Interventions' ClearPoint Neuro Intervention System is being used in the clinical trial to enable direct infusion of the gene therapy into an area of the brain affected by Parkinson's disease.
UC San Diego Health System Utilizes Platform Capabilities of MRI Interventions' ClearPoint System to Conduct Three Back-to-Back Procedures on a Single Patient
GlobeNewswire - Tue Aug 19, 7:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that neurosurgeons at UC San Diego Health System have utilized the ClearPoint system's platform capabilities to facilitate three same-setting MRI-guided neurosurgical procedures for a single patient. The team, led by Clark C. Chen, MD, PhD, vice-chairman of Academic Affairs for the Division of Neurosurgery at UC San Diego School of Medicine, biopsied a patient's brain tumor, aspirated a fluid-filled section of the tumor, and ablated the tumor, all under real-time MRI guidance enabled by the ClearPoint system in the hospital's diagnostic MRI suite.
MRI Interventions Announces Second Quarter 2014 Financial Results
GlobeNewswire - Thu Aug 07, 3:00PM CDT
-- Reports record total product revenues for the quarter
MRI Interventions to Report Second Quarter 2014 Financial Results
GlobeNewswire - Wed Jul 30, 7:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) announced today that it will release its second quarter 2014 financial results on Thursday, August 7, 2014, after the close of the U.S. financial markets. MRI Interventions will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the company's results.
Collaborations in Neurosurgery: MRI Interventions' ClearPoint System and Monteris Medical's NeuroBlate System Utilized Jointly to Enable Laser Ablation of Brain Tumor
GlobeNewswire - Mon Jun 23, 7:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) and Monteris Medical, Corp. jointly announced the utilization of their respective product platforms, the ClearPoint Neuro Intervention System and the NeuroBlate System, at UC San Diego Health System to enable minimally invasive (MR-guided) laser treatment in a patient afflicted with glioblastoma, a type of brain tumor. In a procedure led by Dr. Clark Chen, MD, PhD, Chief of Stereotactic and Radiosurgery and Vice-Chairman of Academic Affairs, MRI Interventions' ClearPoint System was used to establish the path to the tumor while Monteris' NeuroBlate System was used to ablate (heat) tumor cells. The entire procedure was performed within a diagnostic MRI suite at UC San Diego Health System.
MRI Interventions Reports 2013 Financial Results
GlobeNewswire - Thu Mar 20, 3:00PM CDT
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today its financial results for the fourth quarter and year ended December 31, 2013.
MRI Interventions Secures Commitments for $3,550,000 in Private Notes Offering
GlobeNewswire - Mon Mar 10, 7:10AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) announced today that it has entered into a purchase agreement with certain accredited investors for a private placement of securities. Upon a closing under the purchase agreement, which is subject to satisfaction of certain closing conditions, MRI Interventions will receive gross proceeds of $3,550,000, before offering-related expenses. The securities being sold by the company consist of 12% second-priority secured non-convertible promissory notes due 2019 and warrants to purchase 0.3 share of MRI Interventions' common stock for each dollar in principal amount of notes sold by the company, such warrants having an exercise price of $1.75 per share.
MRI Interventions Welcomes Medical Device Operational Specialist Timothy T. Richards to Board of Directors
GlobeNewswire - Mon Mar 10, 7:05AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that its Board of Directors has elected medical device executive Timothy T. Richards to the Board. Mr. Richards' diverse background in the medical technology industry includes over 25 years of international experience spanning the areas of operations, market and product development, and global commercial expansion.
MRI Interventions Announces Quarterly Product Revenues in Excess of $1 Million for the First Time for the Fourth Quarter of 2013
GlobeNewswire - Mon Mar 10, 7:00AM CDT
Full Year Product Revenues Exceed Guidance
MRI Interventions' ClearTrace System to be Featured in Presentation at the 2014 Western Atrial Fibrillation Symposium
GlobeNewswire - Thu Feb 27, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) announced today that its novel ClearTrace system for MRI-guided, catheter-based cardiac procedures will be featured in a presentation at the 7 Annual Western Atrial Fibrillation (AF) Symposium on Feb. 28-March 1 in Park City, Utah. The Western AF Symposium assembles a distinguished faculty of physicians and researchers from five continents to discuss the disorder, its relationship to heart failure, standards for patient care and technical advancements in the field.
MRI Interventions and Siemens Enter Into Agreement to Commercialize Next Generation Software Platform to Enable MRI-Guided, Catheter-Based Procedures
GlobeNewswire - Mon Feb 24, 7:08AM CST
MRI Interventions, Inc. (OTCQB:MRIC) and Siemens Healthcare announced today an agreement to co-develop and commercialize a next generation software platform that will enable minimally invasive catheter-based procedures to be performed under real-time magnetic resonance imaging (MRI) guidance. Today, virtually all catheter-based interventions are performed using fluoroscopy, an X-ray based imaging technique. The software platform, to be used in combination with companion MRI-guided catheters, will enable procedures to be performed under MRI guidance instead of fluoroscopic guidance. This shift to MRI-guided procedures is significant because MRI provides superior visualization of soft tissue, MRI provides continuous 3-D visualization, and MRI eliminates all radiation exposure for the patient and physician.
MRI Interventions to Present at Biotech Showcase 2014
GlobeNewswire - Thu Jan 09, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical technology company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today that Kimble Jenkins, MRI Interventions' Chief Executive Officer, will present at the 2014 Biotech Showcase in San Francisco, California on Wednesday, January 15, 2014. The presentation is scheduled to begin at 4:15 PM Pacific Time. A live webcast of the presentation will be available under the IR Calendar section of the MRI Interventions website. For those unable to listen to the live webcast, a replay will be available on MRI Interventions' website following the presentation.
MRI Interventions' ClearPoint System Utilized at Cincinnati Children's Hospital for Neurosurgical Shunt Placement
GlobeNewswire - Tue Jan 07, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced that the first real-time MRI-guided neurosurgical shunt placement using the company's ClearPoint(R) Neuro Intervention System has been performed at Cincinnati Children's Hospital, representing the latest application of the platform system and illustrating its utility in a wide range of neurosurgical procedures.
MRI Interventions Adds Industry Veteran Maria Sainz as New Board Member
GlobeNewswire - Mon Jan 06, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced that its Board of Directors has elected veteran medical device executive Maria Sainz as its newest director. Ms. Sainz's distinguished career in the medical device industry spans over 20 years, and includes 10 years as the top executive for both emerging businesses and large corporate divisions, strong commercial experience bringing therapies to market, significant international experience, and service on both public and private company boards.
OTC Daily Alert Stock Watch - MRI Interventions, Inc. (OTCQB:MRIC)
WorldStockWire - Wed Dec 18, 4:45AM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
MRI Interventions' ClearPoint Neuro Intervention System Recently Profiled by Boston's ABC-TV Affiliate
GlobeNewswire - Mon Dec 16, 7:00AM CST
The ClearPoint Neuro Intervention System developed by MRI Interventions, Inc. (OTCQB:MRIC) was featured December 10 in a television segment and article reported by the ABC-TV affiliate in Boston (WCVB-TV).
Brain Cancer Lesion Treated with Precisely-Aimed Laser Catheter using ClearPoint Neuro Intervention System in IMRIS iMRI
CNW Group - Tue Aug 20, 7:01AM CDT
Newest joint application of two enabling medical technologies exhibits benefits of intraoperative MRI for direct visualization when navigating to treat brain tumors and neurological disorders
MRI Interventions' ClearPoint System Enables Precise Delivery of Promising Investigational Gene Therapy in Parkinson's Disease Phase I Clinical Trial
Marketwire - Mon Aug 12, 9:07AM CDT
MRI Interventions, Inc. (OTCQB: MRIC) today announced treatment of the first patient in a Phase I clinical trial utilizing uniQure B.V.'s glial cell line-derived neurotrophic factor (GDNF) for treatment of Parkinson's disease. This gene therapy holds promise in the battle against the degenerative and debilitating disorder, which affects 1.5 million people in the United States. MRI Interventions' ClearPoint Neuro Intervention System is being used in the clinical trial to enable direct infusion of the gene therapy into an area of the brain affected by Parkinson's disease.
